Indeed, IL6 is a target of FOXA, a transcription factor regulating estrogen and androgen signaling [141], and estrogens are known to decrease IL6 production, thus reducing HCC progression [142,143]. The gene discussed is IL6; the disease is hepatocellular carcinoma.